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ABSTRACT
The spine apparatus (SA) is an endoplasmic reticulum-related
organelle that is present in a subset of dendritic spines in cortical
and pyramidal neurons, and plays an important role in Ca2+
homeostasis and dendritic spine plasticity. The protein
synaptopodin is essential for the formation of the SA and is widely
used as a maker for this organelle. However, it is still unclear which
factors contribute to its localization at selected synapses, and how it
triggers local SA formation. In this study, we characterized
development, localization and mobility of synaptopodin clusters in
hippocampal primary neurons, as well as the molecular dynamics
within these clusters. Interestingly, synaptopodin at the shaft-
associated clusters is less dynamic than at spinous clusters. We
identify the actin-based motor proteins myosin V (herein referring to
both themyosin Va and Vb forms) and VI as novel interaction partners
of synaptopodin, and demonstrate that myosin V is important for the
formation and/or maintenance of the SA. We found no evidence of
active microtubule-based transport of synaptopodin. Instead, new
clusters emerge inside spines, which we interpret as the SA being
assembled on-site.
KEY WORDS: Synaptopodin, Spine apparatus, F-actin, Dendritic
spines, Myosin
INTRODUCTION
As an adaptation to their enormous size, neurons have developed a
highly sophisticated trafficking system that mediates long-distance
transport and local control of membrane and protein turnover
(Hanus and Ehlers, 2016). Thus, most types of secretory membrane
organelles, which are usually localized in the soma, can also be
found in dendrites (Hanus et al., 2014; Mikhaylova et al., 2016).
One key organelle is the endoplasmic reticulum (ER), which in all
eukaryotic cells is important for lipid and membrane protein
synthesis and transport, as well as for Ca2+ homeostasis. In neurons,
the highly complex ER spans the entire cell, including soma, axon
and dendritic tree, and is even found in dendritic spines (Toresson
and Grant, 2005). Presence of the ER in dendritic spines varies
between different neuronal cell types. Almost every single spine of
cerebellar Purkinje neurons contains a tubule of smooth ER
associated with the spinous actin cytoskeleton (Wagner et al.,
2011a). In contrast, the majority of dendritic spines of pyramidal
neurons in the cortex and hippocampus do not contain ER (Toresson
and Grant, 2005). However, in those cells a subset of spines contain
a complex ER-based organelle called the spine apparatus (SA;
Deller et al., 2003). The SA is usually localized in the spine neck or
at the base of the spine head and consists of laminar ER stacks with
intervening electron-dense plates, connected to the main ER
network. This intriguing structure serves as a Ca2+ store and is
important for synaptic plasticity (Deller et al., 2003).
The protein synaptopodin is an essential component of the SA
structure, since dendritic spines of synaptopodin-deficient mice can
contain single ER tubules but are devoid of the SA, and expression
of synaptopodin is sufficient to rescue this phenotype (Deller et al.,
2003, 2007; Vlachos et al., 2013). Accordingly, cerebellar Purkinje
neurons, which do not express synaptopodin, do not form the SA
despite having ER tubules in all their numerous spines. Of note,
synaptopodin is also required for the establishment of a similar ER-
based structure, called the cisternal organelle, in the axon initial
segment (AIS; Bas Orth et al., 2007). Expression of synaptopodin,
which is restricted to renal podocytes and telencephalic neurons in
the brain, is developmentally regulated and coincides with synaptic
maturation (Czarnecki et al., 2005; Mundel et al., 1997).
Synaptopodin is a cytosolic protein. It lacks a clear domain
organization, contains several predicted disordered regions, and is
known as an actin- and α-actinin-binding protein (Asanuma et al.,
2005; Chalovich and Schroeter, 2010; Kremerskothen et al., 2005).
It has been demonstrated that ∼20–30% of dendritic spines are
positive for synaptopodin, and that it is more frequently present in a
subset of spines with a large spine head volume (Vlachos et al.,
2009; Holbro et al., 2009). Interestingly, the presence of
synaptopodin correlates with synaptic strength, indicating that
SA-containing spines might have different plastic properties
(Korkotian et al., 2014; Vlachos et al., 2009). Along the same
lines, the presence of a SA has been shown to regulate the diffusion
of metabotropic mGluR5 glutamate receptors in and out of spines
(Wang et al., 2016). Accordingly, synaptopodin−/− mice show
impaired long-term potentiation (LTP) and spatial learning (Deller
et al., 2003; Korkotian et al., 2014).Received 21 January 2019; Accepted 19 July 2019
1DFG Emmy Noether Group ‘Neuronal Protein Transport’, Center for Molecular
Neurobiology, ZMNH, University Medical Center Hamburg-Eppendorf, 20251
Hamburg, Germany. 2Institute for Synaptic Physiology, Center for Molecular
Neurobiology, ZMNH, University Medical Center Hamburg-Eppendorf, 20251
Hamburg, Germany. 3Institute of Structural Neurobiology, Center for Molecular
Neurobiology Hamburg, ZMNH, University Medical Center Hamburg-Eppendorf,
20251 Hamburg, Germany. 4Institute of Clinical Neuroanatomy, Faculty of
Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. 5Center for Proteomics,
Erasmus MC, 3000 CA Rotterdam, The Netherlands. 6Cell Biology and Physiology
Center, National Heart, Lung Blood Institute, National Institutes of Health, Bethesda,
MD 20814, USA. 7Department of Molecular Neurogenetics, Center for Molecular
Neurobiology, ZMNH, University Medical Center Hamburg-Eppendorf, 20251
Hamburg, Germany.
*These authors contributed equally to this work
†Deceased
‡Author for correspondence (marina.mikhaylova@zmnh.uni-hamburg.de)
M.M., 0000-0001-7646-1346
This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution and reproduction in any medium provided that the original work is properly attributed.
1
© 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs230177. doi:10.1242/jcs.230177
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Notably, synaptopodin mRNA and protein levels are regulated by
neuronal activity. For example, it has been shown that in dentate
granule cells synaptopodin expression is upregulated following LTP
in vivo (Yamazaki et al., 2001). Moreover, a recent study has found
that synaptopodin is required for cAMP-mediated LTP in
developing neurons and that it is most likely a substrate of protein
kinase A (PKA), which becomes activated during LTP (Zhang et al.,
2013). Taken together, these data suggest that synaptopodin acts as a
powerful tool to induce formation of the SA in dendritic spines, and
it is very likely that synaptopodin expression, localization, function
and stability are highly regulated.
Despite the importance of the SA in synaptic function, there are
still many open questions about the origin of this organelle. For
instance, it is unclear how synaptopodin and the SA are localized to
a selected subset of dendritic spines. Is the complete SA actively
transported along the dendrite and then targeted to selected spines,
or it is assembled locally as needed? What are the molecular
mechanisms that regulate SA localization?
In this study, we aimed to address these questions and to learn
more about the dynamics of the spinous ER and synaptopodin in
hippocampal neurons. In order to identify factors that allow for
synaptopodin localization at postsynaptic sites, we performed a
mass spectrometric analysis of brain-specific binding partners
isolated via a pulldown assay. Interestingly, several myosins stood
out as potential binding partners, including the processive motors
myosin V (herein referring to both the myosin Va and Vb forms) and
VI. While doing long-term live-cell imaging of primary neurons
transfected with GFP–synaptopodin, we found no evidence of
synaptopodin clusters being actively transported along dendritic
branches. Instead, we observed gradual formation of clusters in
spines, which we interpret as the SA being assembled on-site.
Through analyzing myosin Va and myosin VI dominant-negative
approaches, pharmacology and myosin VI-deficient mice, we show
that myosin VI is dispensable for the spine localization of
synaptopodin, whereas myosin V affected the formation and/or
maintenance of synaptopodin clusters, resulting in diminished
synaptic targeting of synaptopodin and the SA.
RESULTS
Processive myosins are novel interactors of synaptopodin
In humans and rodents, three splice isoforms of synaptopodin have
been identified, but only the shortest isoform is found in the brain
(Asanuma et al., 2005; Chalovich and Schroeter, 2010; Fig. S1).
Previously, an interaction between the long splice isoform of human
synaptopodin (UniProt identifier Q8N3V7-2; 903 amino acids) and
α-actinin-2 has been suggested to mediate localization of
(overexpressed) synaptopodin at spines via a binding motif at the
C-terminus (Kremerskothen et al., 2005; Fig. S1). However several
other studies have reported that the short splice isoform of mouse
synaptopodin, lacking the proposed targeting domain, is also clearly
enriched at spines (Fig. S1; Korkotian et al., 2014; Vlachos et al.,
2009). Asanuma et al. showed that this short splice isoform contains
two α-actinin-2- and α-actinin-4-binding sites of its own, but they
did not study synaptopodin in brain (Asanuma et al., 2005).
α-Actinin is non-selectively enriched in all types of spines, thus its
role in localizing synpatopodin and the SA to selected spines is
questionable (Hodges et al., 2014; Matt et al., 2018; Nakagawa
et al., 2004). In order to identify the molecular mechanisms that
govern the distribution of synaptopodin, we set out to first obtain
unbiased information about the brain-specific synaptopodin
interactome (the 690-amino-acid isoform; Fig. S1). Through a
mass spectrometric analysis of a pulldown fraction from rat
hippocampus with biotinylated synaptopodin produced in
HEK293T cells (Fig. 1A,B), we found several known (including
actinins, actin and 14-3-3 proteins) and many novel putative
synaptopodin interaction partners (Fig. 1B; Tables S1, S2).
Interestingly, the CamKIIα and CamKIIβ isoforms were also
present in complex with synaptopodin, an interaction previously
only known from renal podocytes (Faul et al., 2008). Newly
identified proteins include several actin-stabilizing, -capping,
-severing and -modifying proteins including tropomodulins
(Tmod2, Tmod3), gelsolin (Gsn), Arp2/3 complex members
(Arpc2), coronins (Coro2a and Coro2b) and F-actin-capping
proteins (Capza1 and Capza2) (Fig. 1B; Tables S1, S2). This
finding indicates that the association of synaptopodin and actin
filaments might be more complex than just direct binding to actin
and can be subjected to regulation. While we found no kinesin or
dynein motor proteins, nor their adaptors present in the
synaptopodin complex (Table S1), the fact that there were
unconventional myosins as putative prominent binding partners
attracted our attention (Fig. 1B). Processive myosin V and VI are
highly expressed in pyramidal neurons. They mediate organelle
trafficking in and out of dendritic spines and provide stable
anchoring on actin filaments (Correia et al., 2008; Esteves da Silva
et al., 2015). It has been shown that myosin Va is required for
targeting of the ER into the spines of cerebellar Purkinje neurons
(Wagner et al., 2011a). We hypothesized that the processive
myosins V and VI could transport and anchor synaptopodin to
dendritic spines, thereby mediating the synaptopodin-dependent
formation of the spine apparatus. To verify these interactions, we
performed a pulldown assay from rat hippocampus, and analyzed
individual interactors via western blotting. This confirmed the
association of bio-GFP–synaptopodin but not the bio-GFP control
with the endogenous myosin Va, Vb, VI and Id (Fig. 1C). Interestingly,
we found that β-actin was present in the synaptopodin–myosin Va
complex formed in rat brain lysate, but not in the extract fromHEK293T
cells (Fig. 1D). Since all reactions were performed on ice and in the
presence of detergents, the actin associated with the synaptopodin-
beads must be either G-actin or a specific type of highly stabilized
F-actin from the brain lysate. To further confirm the association of
synaptopodin with processive myosins in the brain, we isolated a
synaptosome-enriched fraction from rat cortex and hippocampus
and immunostained it for endogenous synaptopodin, myosin Va,
myosin VI and SHANK3, as a post-synaptic marker. This assay
indicated that synaptopodin-positive synaptosomes indeed contain
myosins (Fig. 1E). We therefore decided to investigate the role of
these myosins in the synaptic targeting of synaptopodin.
Synaptopodin is mainly present in spines containing ER and
is upregulated during neuronal development
While synaptopodin labeling is frequently used as a marker for the
SA (Deller et al., 2000, 2003), here we initially asked how the
presence of ER in dendritic spines correlated with the presence of
synaptopodin by using organotypic hippocampal slice cultures.
Two-photon imaging of CA1 neurons electroporated with plasmids
encoding tdimer2 as a morphology marker and ER–GFP as a label
for the ER followed by post-hoc fixation and immunolabeling with a
synaptopodin-specific antibody indicated that 71% of spines
containing ER were also synaptopodin positive, and only 5% of
spines without ER contained synaptopodin (Fig. S2A–C); therefore,
we conclude that these spines contain a SA.
The expression of synaptopodin is developmentally regulated and
coincides with synaptogenesis. This has been shown repeatedly in
brain slices using antibody-staining against synaptopodin, as well as
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in situ hybridization to detect synaptopodin mRNA (Mundel et al.,
1997; Czarnecki et al., 2005). However, no comprehensive timeline
has been established for dissociated cultures of primary neurons.We
therefore decided to analyze the expression of synaptopodin
systematically and to establish a timeline of synaptopodin
expression in hippocampal neurons prepared from embryonic day
(E)18 rat embryos. Confocal imaging showed that at 5 days in vitro
(DIV5) there were very few synaptopodin puncta found in dendrites
labeled by MAP2 staining. At DIV10, a clear synaptopodin signal
was detectable (Fig. 2A). The total number of puncta increased until
DIV15 (Fig. 2B,C). Similarly, immunoblotting of cell lysates
prepared from DIV5, 10, 15 and 21 primary hippocampal cultures
indicated a gradual increase in synaptopodin expression during
neuronal development and maturation (Fig. 2D). In the next set of
experiments, we also stained for the postsynaptic marker homer1
and used the F-actin marker phalloidin, to visualize dendritic
spines. We observed an increased colocalization of synaptopodin
with homer1 in mature cultures (Fig. 2E,F). On average, ∼3% of
synaptopodin puncta were adjacent to homer1-positive synapses in
DIV5 neurons, while this number increased to 48%, 64% and 62%
at DIV10, DIV15 and DIV21, respectively (Fig. 2F), indicating an
increase in synaptic association of synaptopodin clusters.
Interestingly, we observed a large number of synaptopodin
clusters adjacent to homer1 in locations that seem to be inside
the dendritic shaft, as opposed to spine localization. Some of those
certainly can be accounted for by spines that reach out
Fig. 1. Myosin family proteins are novel interaction partners of synaptopodin. (A) SDS-polyacrylamide gel of the bio-GFP–synaptopodin (SYNPO) and bio-
GFP (control) pulldown used for mass spectrometric analysis. Biotinylated GFP–synaptopodin was expressed in HEK293 cells and bound to Streptavidin beads.
The beads were then incubated with rat brain lysate to pulldown brain-specific interactors of synaptopodin. (B) Network analysis of selected potential
synaptopodin interactors identified in the mass spectrometry analysis (Table S1) using the online STRING analysis tool. Highlighted in blue are known
synaptopodin-interacting proteins including actin (Actg1, Actb) and actinins (Actn2, Actn4). In red are myosins that were later tested positively in the co-
immunoprecipitation shown in D. Line thickness indicates strength of data support. (C)Western blot analysis of bio-GFP–synaptopodin pulldown from brain lysate
confirms interaction with myosin Va, Vb, VI and Id. Input, brain lysate; Strept-HRP, streptavidin coupled to horseradish peroxidase. Arrows indicate the expected
molecular mass of bio-GFP–synaptopodin (upper) and bio-GFP (lower). (D) Western blot analysis of bio-GFP–synaptopodin pulldown probed for the presence of
actin before and after incubation with brain lysate. Bio-GFP–synaptopodin-coupled beads are not enriched with myosin Va or actin coming from the HEK293 cells,
but show association with myosin Va and actin specifically from brain lysate. BL, brain lysate. Beads w/o, bio-GFP–synaptopodin-coupled beads before
incubation in brain lysate. Beads+BL, bio-GFP–synaptopodin-coupled beads after incubation in brain lysate. (E) Immunostaining of synaptosome-enriched
fraction from rat brain. Synaptosomes were enriched from brain lysate using differential centrifugation and stained with antibodies against Shank3 (post-synaptic
marker), synaptopodin and myosin V or VI. Both myosin V and VI could are found at synaptopodin- and Shank3-containing structures. Scale bar: 2 µm.
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orthogonally to the plane of view. However, such spines are
generally rare in primary neuronal culture, and we speculate that
some of these sites might constitute excitatory shaft synapses that
are associated with synaptopodin clusters, or even a proper SA
structure. Taken together, these data show that synaptopodin
expression increases during synaptogenesis and synaptic
maturation in primary neuronal culture, and DIV15–21 neurons
can be used as a cell culture model to study mechanisms regulating
synaptopodin cluster localization and formation in dendritic
spines.
Synaptopodin clusters are closely associated with F-actin
Synaptopodin is an actin-associated protein (Asanuma et al., 2005;
Kremerskothen et al., 2005; Mundel et al., 1997). However, the
spatial relation of synaptopodin puncta to neuronal F-actin has never
been resolved in detail, owing to the diffraction limit of fluorescence
imaging techniques used in earlier studies (Sánchez-Ponce et al.,
2012; Vlachos et al., 2009). Only recently, super-resolution imaging
based on stochastic optical reconstruction microscopy (STORM)
and photoactivated localization microscopy (PALM) were used to
show the association of overexpressed Dendra–synaptopodin with F-
Fig. 2. See next page for legend.
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actin in the neck of dendritic spines in hippocampal primary neurons
(Wang et al., 2016). Here, we decided to visualize endogenous
synaptopodin by employing stimulated emission depletion (STED)
nanoscopy. To this end, we stained hippocampal primary neurons
with antibodies against synaptopodin and MAP2 or homer1, while
the F-actin cytoskeleton was visualized by means of phalloidin–
Atto647N. Two-color STED imaging of synaptopodin and F-actin
indicated that synaptopodin-labeled structures were embedded inside
an F-actin mesh both at the spine- and shaft localizations, as well as
the AIS (Fig. 3A–D). As already shown in Fig. 2E,F, we again
identified synaptopodin clusters close to homer1-positive synapses
inside the dendritic shaft, which we hypothesize to constitute shaft-
synapse-associated SAs. This leaves the question about the function
of non-synapse-associated synaptopodin puncta inside the shaft. We
suggest that, in analogy to the AIS, dendrites also may contain an
equivalent of the cisternal organelle (Fig. 3C, blue arrow) that could
be involved in dendritic Ca2+ regulation and buffering. In some cases,
we were able to resolve a stack-like organization of individual
synaptopodin clusters in dendrites, similar to those found in the AIS
(Fig. 3D), which speaks in favor of this hypothesis. However, these
occasions were rare since the stacks need to be perfectly orthogonal to
the imaging plane to visualize them.
Comparative analysis of synaptopodin puncta showed that there
were no significant differences in size distribution between spine-
localized clusters and those in the shaft (Fig. 3E). In both cases more
than 90% of them were enriched in F-actin (Fig. 3F) and there was a
clear correlation between the intensity of synaptopodin and F-actin
levels (Fig. 3G). Conversely, only 12% of the spine-associated
clusters contained MAP2 (negative control, Fig. S3A). STED
imaging revealed that homer1 signals were frequently adjacent to
the synaptopodin clusters, but only in 17–24% of the cases was the
signal directly overlapping (Fig. S3B). In a very recent study, we
have shown that trafficking and localization of dendritic lysosomes
is influenced by the presence of F-actin patches in dendrites, and
that the long-term stalling of lysosomes is mediated by myosin V
(Van Bommel et al., 2019). Therefore, we hypothesized that
likewise, myosin V (or myosin VI) might play a role in dendritic
targeting of synaptopodin, and decided to take a closer look at these
motor proteins.
Synaptopodin cluster numbers and their association with
the ER in spines depend on myosin V
To test the contribution of myosin V and VI to the localization of
synaptopodin clusters, we used a dominant-negative (DN) approach
to inhibit the function of those myosins (Osterweil et al., 2005; Wu
et al., 2002). The DN effect is achieved through overexpression of
the C-terminal myosin cargo-binding domain, which competes with
the endogenous myosin for cargo binding. Overexpression of the C-
terminal myosin Va cargo-binding domain is well known to impair
the function of endogenous myosin Va (Balasanyan and Arnold,
2014; Correia et al., 2008; Jones et al., 2000). Here, we developed a
novel DN construct comprising only the globular tail domain of
myosin Va, which dimerizes through a leucine zipper (LZ) in order
to avoid additional effects mediated by the CC region that might
sequester further interaction partners from their physiological
targets. To verify the inhibitory effect of the myosin Va DN
construct, we used Purkinje cells, since myosin Va is already known
to mediate the targeting of ER into their dendritic spines (Fig. S3C).
Confocal live imaging of primary mouse Purkinje cells showed that
both constructs, that is with either the myosin Va CCor the LZ fused
to the globular tail domain of the myosin, exert a DN effect on ER
targeting to spines (Fig. S3C). Therefore, we decided to use the
minimized LZ–globular domain fusion construct (hereafter referred
to as MyoV DN) under the control of the human synapsin 1
promoter in hippocampal neurons. Similarly, the cargo-binding
domain of myosin VI (MyoVI DN) fused to GFP and expressed
under the synapsin promoter was used to inhibit myosin VI function
(Van Bommel et al., 2019). We transfected DIV15–16 primary
hippocampal neurons with DN constructs or corresponding
controls, fixed them after 1 day of expression and stained for
endogenous synaptopodin and homer1 (Fig. 4A–D). Both
overexpressed DN constructs entirely filled dendrites and spines
and thus could be used as a volume marker (Fig. 4A,C). MyoV DN
expression resulted in a significant reduction of total synaptopodin
clusters compared to control (on average 13.5 per 40 µm in MyoV
DN and 24 per 40 µm in mCerulean control; Fig. 4B). Significantly
less synaptopodin puncta were found in association with dendritic
spines (Fig. 4B). Importantly, the total number of homer1-positive
dendritic spines did not change (Fig. 4B). This indicates that myosin
Va is required for the formation or stability of synaptopodin clusters
and most likely the associated SA. Although quantification showed
some reduction of synaptopodin puncta following overexpression of
MyoVI DN, the difference to control neurons was not statistically
significant (Fig. 4C,D). To corroborate these findings, we utilized
primary hippocampal cultures from wild-type and myosin VI-
deficient Snell’s waltzer (Myo6sv/sv) mice (Avraham et al., 1995).
Neurons were fixed at DIV8, 14 and 17 and stained for
synaptopodin, homer1 and F-actin (Fig. S4A). Quantification of
confocal images showed that, very similar to what was found for rat
primary neuronal cultures, the number of synaptopodin puncta
increased during development in both wild-type and Myo6sv/sv
dendrites. Those numbers did not significantly differ between the
genotypes (Fig. S4B). In addition, the distribution of homer1-
colocalized synaptopodin clusters to spines and dendritic shafts
was not statistically different in Myo6sv/sv neurons compared to
wild-type (Fig. S4C). Thus, we conclude that the interaction of
Fig. 2. Expression and localization of synaptopodin during development
in hippocampal primary neurons. (A) Representative confocal images of
primary hippocampal neurons on DIV5, DIV10, DIV15 and DIV21 stained with
anti-synaptopodin (SYNPO) and anti-MAP2 antibodies. Scale bars: 5 µm.
(B) Quantification (mean±s.e.m.) of the average number of total synaptopodin
puncta per 40 µm dendritic segments at DIV5, DIV10, DIV15 and DIV21.
Kruskal–Wallis-Test with Dunnett’s post hoc test *P=0.0493 (DIV5 vs DIV10),
P=0.0421 (DIV10 vs DIV15); n.s., not significant. (C) Quantification (mean±
s.e.m.) of synaptopodin puncta present inside or outside (spines, filopodia) of
dendritic shafts. Kruskal–Wallis-Test with Dunnett’s post hoc test **P=0.0077
(DIV5 vs DIV10). In B and C, DIV5, n=13 cells from three independent cultures
with 44 dendritic segments counted; DIV10, n=14 cells from three independent
cultures with 63 separate segments counted; DIV15, n=14 cells from two
independent cultures with 93 separate segments counted; DIV21, n=16 cells
from three independent cultures with 100 separate segments counted. (D)
Immunoblot showing developmental expression of synaptopodin in primary
hippocampal cultures. β-actin is used as loading control. (E) Representative
confocal image of primary hippocampal neurons at DIV10, DIV15 and DIV21
stained with anti-synaptopodin, anti-homer1 and phalloidin–A647N. Red
arrowheads, colocalization of synaptopodin and homer1 in dendrite; green
arrowheads, colocalization in spine; White arrowheads, no colocalization.
Scale bars: 5 µm. (F) Quantification (mean±s.e.m.) of the percentage of
synaptopodin puncta colocalizing with homer1 in different dendritic
subcompartments. Mixed ANOVA with DIV as between and localization as
within group factors. F(4, 36)=4.4359, P=0.00512. Newman–Keuls post hoc
test, *P=0.0348 (no coloc DIV10 vs DIV15), P=0.0435 (DIV15 vs DIV21
dendrite). DIV5, n=13 cells from three independent cultures with 44 separate
segments counted; DIV10, n=8 cells from three independent cultures with 44
separate segments counted; DIV15, n=7 cells from two independent cultures
with 35 separate segments counted; DIV21, n=8 cells from two independent
cultures with 41 separate segments counted.
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synaptopodin with myosin V, but not VI, is essential for the
formation of synaptopodin clusters and for their normal distribution
to dendritic spines.
Since the number of synaptically localized synaptopodin clusters
was reduced upon inhibition of myosin V, next we asked whether
this would also affect SA formation. To test this, we co-transfected
Fig. 3. Synaptopodin is closely associated with F-actin in spines and inside dendritic shafts. (A) Confocal overview image of a DIV17 primary hippocampal
neuron with F-actin stained by phalloidin–A647N and immunostaining of endogenous synaptopodin (SYNPO) and MAP2. White arrowheads indicate the AIS.
Scale bar: 10 µm. (B) Confocal (MAP2) and STED image (phalloidin, synaptopodin) showing F-actin-enriched synaptopodin patches in spine necks and dendritic
shafts. Scale bar: 2 µm. (C) Upper row, STED image of DIV17 hippocampal neuron stained for homer1, synaptopodin and F-actin (phalloidin). The box indicates
the ROI shown in higher magnification in lower row. White arrowheads indicate homer1-positive synapses (SpS, spine synapse; ShS, shaft synapse). The shaft
synapse is also associated with synaptopodin. Blue arrowheads indicate a dendritic synaptopodin cluster positive for F-actin but not associated with a synapse.
Scale bar: 2 µm. (D) Comparison of the cisternal organelle found in the AIS (upper row) and dendritic synaptopodin patches (middle row). The lower row shows
line profiles of phalloidin (F-actin) and synaptopodin intensity of the cisternal organelle (1) and dendritic synaptopodin patch (2). Scale bars: 2 µm (upper), 1 µm
(middle). (E) Size distribution of synaptopodin patches associated with a synaptic spine or the dendritic shaft. Mann–Whitney U-test, P=0.35. Shaft-associated
spots, n=153; spine-associated spots, n=105 from 20 dendritic segments of 17 neurons in two independent cultures. (F) Quantification of shaft- and spine-
associated synaptopodin patches that are colocalizing with F-actin. n=20 dendritic segments of 17 neurons in two independent cultures. (G) Correlation of
fluorescence intensity of synaptopodin and F-actin in shaft- and spine-associated synaptopodin patches. Shaft-associated patches: n=141; spine-associated
patches, n=99; from 20 dendritic segments of 17 neurons in two independent cultures.
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Fig. 4. Myosin V but not myosin VI inhibition affects spine localization of synaptopodin puncta. (A) Representative confocal images of primary
hippocampal neurons on DIV16 transfected with mCerulean (control) or Myosin-V-DN–mCerulean (MyoV DN) and stained with anti-synaptopodin (SYNPO) and
anti-homer1 antibodies. Scale bar: 5 µm. (B) Quantification (mean±s.e.m.) of the number of total synaptopodin puncta (left), the number of homer1-positive
spines containing synaptopodin (middle), and the total number of homer1-positive spines (right) per 40 µm dendritic segments in control and MyoV DN-
expressing neurons. MyoV DN expression led to a decrease in total synaptopodin puncta (two-tailed unpaired t-test, *P=0.0218), and in puncta localizing to
homer1-positive spines (two-tailed unpaired t-test, **P=0.0100), while the total number of spines was unchanged. MyoV DN, n=27 cells from four independent
experiments with 51 segments counted. mCerulean, n=22 cells from four independent experiments with 54 segments counted. (C) Representative confocal
image of primary hippocampal neurons on DIV16 transfected with mRuby2 (control) or GFP–Myosin-VI-dominant-negative (MyoVI DN) and stained with anti-
synaptopodin and anti-MAP2 antibodies. Single-color channel and merged images are shown. Scale bar: 5 µm. (D) Quantification (mean±s.e.m.) of the number
of total synaptopodin puncta (left), the number of homer1-positive spines containing synaptopodin (middle), and the total number of homer1-positive spines (right)
per 40 µm dendritic segments in control andMyoVI DN-expressing neurons. Unpaired t-test (two-tailed) showed no significant change (ns). Left, Myo VI DN, n=21
cells from four independent experiments with 66 segments counted. Control, n=16 cells from four independent experiments with 40 segments counted. Middle
and right, Myo VI DN, n=12 cells from two independent experiments with 21 segments counted. Control: n=10 cells from two independent experiments with 18
segments counted.
7
RESEARCH ARTICLE Journal of Cell Science (2019) 132, jcs230177. doi:10.1242/jcs.230177
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
primary neurons with an ER marker fused to DsRed and either
MyoV DN, MyoVI DN or control plasmids, and fixed them after 1
day of expression. Since the DsRed signal proved to be too dim and
prone to bleaching during imaging, in addition to the endogenous
synaptopodin immunostaining, we stained the ER marker with an
anti-RFP AbberiorStar-580 FluoTag (NanoTag). Confocal imaging
showed that, similar to what was found in organotypic slices (Fig.
S2), ER tubules could be seen inside a subset of dendritic spines
(Fig. 5A). We interpreted colocalization of synaptopodin and the
ER inside a dendritic spine as a SA. Quantitative analysis indicated
that, as above, the total number of synaptopodin puncta was reduced
upon overexpression of MyoV DN, but not MyoVI DN (Fig. 5B,C).
The number of synaptopodin only- or the ERonly-containing spines
was slightly but not significantly decreased (Fig. S5A,B) but the
number of spines containing both the ER marker and synaptopodin
(SA) was reduced specifically after expression of MyoV DN
(Fig. 5B), whereas the total spine density was again not affected by
overexpression of either construct (Fig. 5B,C). From this, we
conclude that inhibition of myosin V negatively affects the
formation of the SA.
Synaptopodin clusters do not exhibit processive trafficking,
but show differences in their molecular dynamics depending
on their localization
As shown previously, the distribution of overexpressed GFP–
synaptopodin closely matches the distribution of the endogenous
protein (Vlachos et al., 2009). Here, we generated a construct for
GFP–synaptopodin expression under the human synapsin 1
promoter, which is frequently used for low-to-moderate neuron-
specific expression of proteins in primary neurons and organotypic
Fig. 5. Myosin V inhibition affects the
number of spines containing both
synaptopodin and the ER. (A)
Representative confocal images of
primary hippocampal neurons on DIV17
transfected with an ER marker and a cell
fill (YFP; control) or MyoV DN, stained
with anti-synaptopodin (SYNPO)
antibody. Arrows indicate dendritic
spines that are positive for both
synaptopodin and ER. Scale bars: 5 µm.
(B) Quantification (mean±s.e.m.) of the
number of synaptopodin puncta (left), the
percentage of spines that are positive for
both synaptopodin and ER (middle), and
the number of spines per 40 µm (right).
MyoV DN showed a decrease in total
synaptopodin puncta (two-tailed
unpaired t-test, *P=0.043) and in spines
containing both synaptopodin and the ER
(two-tailed unpaired t-test, *P=0.0481).
Myo V DN, n=9 cells from two
independent experiments with 22
segments counted. mCerulean, n=9 cells
from two independent experiments with
23 segments counted. (C) Quantification
(mean±s.e.m.) of the number of total
synaptopodin puncta, the percentage of
spines that are positive for both
synaptopodin and ER, and the number of
spines per 40 µm. Myo VI DN, n=10 cells
from two independent experiments with
22 segments counted. Control, n=8 cells
from two independent experiments with
22 segments counted. MyoVI DN had no
significant effect on the measured
parameters (ns).
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slices (Kügler et al., 2003; Mikhaylova et al., 2016). We asked
whether GFP–synaptopodin clusters are actively transported within
the dendrite, and how they are recruited into or removed from
dendritic spines. However, time-lapse imaging of GFP–
synaptopodin and mRuby2 co-expressing neurons did not reveal a
single long-range transport event in dendrites over 1 hour of
imaging with a 2 min interval (Fig. 6A). Synaptopodin puncta in
both spines and dendritic shafts were stably anchored at the same
locations and sometimes oscillated within areas of 1–2 µm
(Fig. 6A). Subsequent staining of lysosomes in the same cell
showed processive bidirectional transport, ensuring that dendritic
cargo trafficking in the observed cell was not compromised in any
way (Fig. 5B). Continued imaging of transfected neurons over a 7 h
period also did not reveal any processive movement of GFP–
synaptopodin clusters (Fig. S5A; Movie 1). These observations are
in line with our mass spectrometry results, as we did not find any
kinesin or dynein motor proteins nor their adaptors present in the
synaptopodin complex (Table S1). Based on this, we rule out the
possibility that clusters of synaptopodin might be actively
transported via long-distance microtubule-dependent active
Fig. 6. See next page for legend.
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transport. This leaves the scenario in which synaptopodin clusters
form locally de novo, possibly via local mRNA translation or
recruitment of soluble synaptopodin, and then build up the SA in
place. Further analysis of live imaging data confirmed that there are
indeed instances where the synaptopodin signal gradually
accumulated in a spine (Fig. 6C; Movie 2).
So far, we found that both dendritic and synaptic synaptopodin
clusters are closely associated with patches of F-actin and are stable
at their locations over many hours (Fig. 3, Fig. 6A; Fig. S5). To
further characterize spine- vs dendritic shaft-localized synaptopodin
clusters, we performed fluorescence recovery after photobleaching
(FRAP) experiments in neurons expressing GFP–synaptopodin and
mRuby2 as a morphology marker (Fig. 6D–G). Interestingly, a
subset of the photobleached synaptopodin clusters did not recover
any fluorescence at all, so only those clusters that recovered at least
10% of their initial fluorescence value were considered in the FRAP
analysis. We found that the recovery rate of spine-localized puncta
was twice as fast as in the shaft (Fig. 6E,F). Incubation of neurons
with a pharmacological myosin V inhibitor, MyoVin, which blocks
the ATPase activity of the motor domains and can thus turn myosin
V from a processive motor into a tether (Gramlich and Klyachko,
2017; Heissler et al., 2017), or with myosin VI inhibitor (TIP) did
not significantly affect the recovery kinetics at either location.
However, the number of recovering synaptopodin puncta was
significantly reduced upon treatment with MyoVin (Fig. 6E–G),
which indicates an involvement of the motor in the local availability
of synaptopodin.
Taken together, it is very likely that synaptopodin and the ER are
locally emerging at synaptic sites to form a SA and myosin V, rather
than myosin VI, is involved in the formation or stabilization of
synaptopodin clusters and/or the SA, and possibly targeting to
specific subcellular sites.
DISCUSSION
Functional and structural properties of dendritic spines containing
the SA differ from their neighbors without the SA, as it plays a key
role in synaptic Ca2+ homeostasis (Korkotian et al., 2014; Vlachos
et al., 2009). An essential component, the protein synaptopodin, is
closely associated with the smooth ER-derived membranes that are
forming the SA. Despite a growing number of studies addressing the
role of the SA in neuronal function, it was still unclear how
synaptopodin or the SA are localized to dendritic spines. In previous
studies, long-term imaging experiments with overexpressed GFP–
synaptopodin in primary hippocampal neurons revealed that
synaptopodin clusters change their position within dendrites or
spines only over large time spans (Vlachos et al., 2009.). However,
since these data were acquired with a 1-day interval, it is difficult to
judge whether synaptopodin clusters were actively relocated as a
whole, or disassembled and newly assembled elsewhere. In this
study, we aimed to characterize molecular dynamics, transport and
synaptic targeting of synaptopodin in more detail.
Imaging of dendritic spines from CA1 hippocampal neurons in
slice cultures indicated that the majority of dendritic spines
containing ER were also positive for synaptopodin. In addition, in
primary hippocampal neurons synaptopodin labels the SA
(Korkotian et al., 2014). Previous studies have described a
developmental regulation of synaptopodin expression, by using
western blots of whole tissue-lysates and staining of hippocampal
slices of post-natal rat pups (Mundel et al., 1997; Czarnecki et al.,
2005). Here, we established a detailed timeline of synaptopodin
expression and synaptic localization in cultured primary
hippocampal neurons. We found that synaptopodin levels and the
degree of synaptic localization increased with the maturation of the
cultures and reached a maximum between DIV15 and DIV21. We
therefore continued to use DIV17–DIV21 cultures for our
experiments. Notably, this development is in accordance with data
published on the synaptopodin-dependent maturation of the
cisternal organelle of the AIS (Sánchez-Ponce et al., 2011, 2012).
Interestingly, we discovered that synaptopodin clusters are not only
found in dendritic spines and the AIS but are also present along the
dendritic shaft. Both spine- and shaft-associated clusters were
closely associated with F-actin, suggesting that not all shaft clusters
were located in proximity to a synapse. It is therefore tempting to
speculate that those, in contrast to SAs, could represent an ER-
associated structure like the cisternal organelle, which is found at the
AIS. Electron microscopy studies combined with immunogold
labeling could shed some light on the identity of these structures in
the future.
Until now there was a limited number of binding partners known
for synaptopodin. Among them were the actin cross-linking α-
actinin proteins (Asanuma et al., 2005). Some of the α-actinin
isoforms are expressed in neurons and highly enriched in dendritic
spines (Hodges et al., 2014; Nakagawa et al., 2004). However, the
ubiquitous presence of α-actinins makes them unlikely to confer
specific targeting of synaptopodin to selected dendritic spines.
Taking this into account, we decided to search for new binding
partners of synaptopodin that could shed some light on the biology
of the spine apparatus. Using eukaryotically produced synaptopodin
as bait we analyzed the brain-specific interactome of synaptopodin
Fig. 6. Synaptopodin puncta are largely immobile and are generated de
novo in dendritic spines, and synaptopodin turnover rate is affected by
inhibition ofmyosin V, but notmyosin VI. (A) 60 min time-lapse imaging of a
primary hippocampal neuron (DIV17) expressing GFP–synaptopodin
(SYNPO) and mRuby2. Images were acquired at a 2 min interval. White
arrowheads indicate synaptopodin puncta that were stably localized over the
entire imaging period. Blue arrowheads indicate puncta that moved over very
short distances (<2 µm). Scale bar: 5 µm. Also see Movie 1. (B) Shown is the
same neuron as in A. Left, image and kymograph of the main dendritic shaft
(dashed line) in the synaptopodin channel over the 60 min imaging period.
Right: After 60 min imaging, Lysotracker Green was added to the imaging
medium and the cell was imaged for 15 s with a 1 s interval. The kymograph
shows moving lysosomes in the previously imaged cell. Scale bars: 5 µm. (C)
Example images from a 110 min time-lapse imaging of a primary hippocampal
neuron (DIV15, outlined with a dashed white line) expressing GFP–
synaptopodin. Images were acquired with a 5 min interval. Synaptopodin
puncta can be observed gradually emerging in dendritic spines (white
arrowheads). Scale bars: 2 µm. Also see Movie 2. (D) Analysis of
synaptopodin dynamics using FRAP. Example images of a DIV17 primary
hippocampal neuron expressing GFP–synaptopodin and mRuby2, before,
during and after photobleaching of selected synaptopodin puncta (asterisks).
(E) FRAP quantification for synaptopodin puncta localized in spines.
Compared were fluorescence recovery rates in control (DMSO) and myosin
V-inhibitor (MyoVin, 30 µM for 20 min) or myosin VI-inhibitor (TIP, 4 µM for
20 min) treated cells. In the analysis, only those puncta that recovered >10% of
their initial fluorescence were considered. One-phase-association fits, n
numbers and plateaus are indicated (DMSO 58±1, MyoVin 52±0.7,
TIP 54±0.8). (F) FRAP quantification for synaptopodin puncta localized in the
dendritic shaft. One-phase-association fits, n numbers and plateaus are
indicated (DMSO 30±0.4, MyoVin 24±0.3, TIP 33±0.5). For E and F, repeated
measures two-way ANOVA showed treatment did not lead to a significant
difference. (G) Percentage of puncta that were considered ‘recovering’
(recovered>10% of their initial fluorescence). One-way ANOVAwith Dunnett’s
post hoc test for DMSO vs MyoVin *P=0.0376. DMSO, n=3 independent
experiments with 84 puncta analyzed; MyoVin, n=4 with 124 puncta analyzed;
TIP, n=3 with 81 puncta analyzed. (H) Model summarizing the role of myosin V
and synaptopodin interaction in localization of the SA to actin filaments
associated with spine or shaft synapses. PSD, post-synaptic density;
SA, spine apparatus; CO, cisternal organelle.
10
RESEARCH ARTICLE Journal of Cell Science (2019) 132, jcs230177. doi:10.1242/jcs.230177
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
by mass spectrometry. In agreement with our live imaging data,
there were no microtubule-based motor proteins or their adaptor
proteins found in the synaptopodin complex. On the other hand, we
detected a number of unique peptides corresponding to CaMKIIα,
CaMKIIβ and 14-3-3 proteins. In renal podocytes, it has been shown
that synaptopodin can be phosphorylated by PKA and CaMKII.
Together with the phosphatase calcineurin, these kinases regulate the
phosphorylation status of synaptopodin and its association with the
protein 14-3-3, which can protect synaptopodin from degradation
(Faul et al., 2008). Therefore, it is plausible that mechanisms similar
to those in podocytes also regulate synaptopodin stability and
degradation in dendritic spines. The most interesting and prominent
interaction partners identified in this screen were several F-actin-
based myosin motors. Processive myosin V and VI play an important
role in a wide range of neuron-specific functions including organelle
and mRNA transport and anchoring (Correia et al., 2008; Esteves da
Silva et al., 2015). Class V myosins represented by myosin Va and
Vb mediate spinous transport of membrane organelles, such as
recycling endosomes, tubules of smooth ER or lysosomes (Wagner
et al., 2011a;Wang et al., 2008; VanBommel et al., 2019).Moreover,
myosin V processivity is regulated by Ca2+ and calmodulin, which
suggests that myosin function could be controlled by synaptic
activity. Myosin VI is implicated in spinous vesicle trafficking as
well, for example in Rab11 recycling endosomes (Esteves da Silva
et al., 2015). These features make myosins very attractive candidates
for synaptic targeting of synaptopodin. Using dominant-negative
constructs, myosin VI-deficient mice and pharmacological inhibitors
of myosin V and VI we found that interferencewith myosin V but not
myosin VI reduced the number of synaptopodin clusters, as well as
spinous targeting of synaptopodin and of the spine apparatus.
Interestingly, when we performed time-lapse imaging of GFP–
synaptopodin-transfected neurons over extended periods of time,
we observed only very short-distance movements (<2 µm) of
synaptopodin puncta, and no long-distance trafficking events. This
indicates that under basal conditions, synaptopodin clusters are
stably localized and immobile. On the other hand, we observed that
new synaptopodin clusters emerged on-site in dendritic spines and
persisted over long time periods. Interestingly, GFP–synaptopodin
clusters in dendritic spines and in the shaft had very different
molecular dynamics: after photobleaching, spine-associated clusters
recovered fluorescence intensity much faster than shaft-associated
clusters, indicating that spine-localized clusters contain a larger
dynamic pool of synaptopodin. Since both shaft- and spine-localized
synaptopodin clusters are associated with the F-actin cytoskeleton,
and the turnover rate of F-actin is the same in both locations (Van
Bommel et al., 2019), it is unlikely that actin dynamics play a role in
synaptopodin stability. One possible explanation could be that spine-
associated synaptopodin clusters represent the SA, whereas shaft-
associated clusters might constitute a different kind of ER-based
compartment, possibly more similar to cisternal organelles. In this
case, the differences in synaptopodin stability are due to the different
nature and molecular composition of those organelles. Furthermore,
we found that interaction with myosin V is important for recruitment
and clustering of synaptopodin molecules at F-actin-rich areas. It is
plausible that synaptic activity has an influence on synaptopodin
accumulation, for example, via control of myosin V activity, or via
downstream phosphorylation of synaptopodin. This would provide
an additional explanation for the differences observed in spine- and
shaft-localized synaptopodin dynamics.
As for the involvement of myosin V, there are several possible
scenarios as to how it could contribute to SA formation. We
speculate that, since myosin V is responsible for targeting the ER to
synaptic spines in Purkinje neurons, it might also fulfil this role in
hippocampal neurons. It is conceivable that myosin V is required to
initially localize an ER protrusion to a dendritic spine, which would
be followed by accumulation of synaptopodin and formation of the
SA (Fig. 6H). Alternatively, spinous accumulation of synaptopodin
clusters via myosin V could be the necessary first step in localized
SA formation, followed by the capture of a transient ER protrusion.
This clustering could be achieved via interaction of synaptopodin
with actin-bound myosin V, or via anchoring of dendritic
synaptopodin mRNA that is then locally translated (Balasanyan
and Arnold, 2014). In our experiments, we could not discriminate
between these scenarios. Considering that the activity of myosin V
is Ca2+ dependent, in future studies it would be interesting to test
whether the SA relocates in response to synaptic activity, as this
could provide selectivity for synaptic targeting.
Taken all together, the results of this study extend our
understanding on how synaptopodin and presumably the SA are
targeted to the synapses via association with myosin V and actin
filaments.
MATERIALS AND METHODS
Constructs
To produce the pEGFP-bio-synaptopodin construct, synaptopodin (mouse
isoform 3, UniProt identifier Q8CC35-3) was subcloned from a pEGFP-
Synaptopodin plasmid (Asanuma et al., 2005) into pEGFP-C1-bio (a kind
gift from Anna Akhmanova, Utrecht University, Utrecht, The Netherlands)
with SacII and SalI restriction. For cloning of the hSyn1–GFP–synaptopodin
construct, GFP–synaptopodin was amplified via PCR, and pAAV-hSyn1-
mRuby2 was digested with EcoR1 and HindIII to remove mRuby2. GFP–
synaptopodin was inserted into the digested plasmid via homologous
recombination (Jacobus and Gross, 2015). To produce the MyoVI
DN construct, the Syn–GFP–synaptopodin vector was digested with
HindIII and NdeI to remove synaptopodin, and the C-terminal domain of
mouse myosin VI (bp 3177-3789; NCBI reference sequence:
NM_001039546.2) was amplified via PCR and cloned into the backbone
(Aschenbrenner et al., 2003).
Purkinje-specific expression plasmids pL7, pL7-mCER, pL7-mRFP-
ER-IRES-GFP were described previously (Wagner et al., 2011b; 2011a).
Plasmid pL7-mCER-Myo5a-CC-GTD corresponds to pL7-mCER
containing a cDNA encoding the C-terminal part of mouse MYO5A
(starting at residue 1194 of the brain-spliced isoform, transcript variant
X6; NCBI reference sequence XM_006510832.3) inserted in frame at the
3′-end of the mCerulean-coding sequence. Similarly, pL7-mCER-
Myo5a-GTD carries a cDNA encoding the globular tail domain of
mouse MYO5A (starting at residue 1415, numbering according to brain-
spliced isoform). Plasmid pL7-mCER-LZ was generated by inserting a
sequence encoding the leucine zipper of GCN4 (MKQLEDKVEELLSK
NYHLENEVARLKKLVGE) in frame at the 3′-end of the mCerulean-coding
sequence. To generate pL7-mCER-LZ-Myo5a-GTD, a sequence encoding the
globular tail domain of mouse MYO5A (starting at residue 1415, numbering
according to brain-spliced isoform) was inserted in frame at the 3′-end of the
leucine zipper of pL7-mCER-LZ.
A complete list of expression constructs used in this study is provided in
Table S3.
Antibodies and pharmacological components
Details of antibodies used are provided in Table S4, and pharmacological
components in Table S5.
Animals
Wistar rats Crl:WI(Han) (Charles River) and Wistar Unilever HsdCpb:WU
(Envigo) rats were used in this study. Pregnant rats were euthanized for
primary hippocampal cultures (E18), post-natal day (P)0 mice were used for
primary cultures, female P5–6 rat pups for organotypic slice cultures and
adult female rats for biochemistry. Animal experiments were carried out in
accordance with the European Communities Council Directive (20110/63/
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EU) and the Animal Welfare Law of the Federal Republic of Germany
(Tierschutzgesetz der Bundersrepublik Deutschland, TierSchG) approved
by the local authorities of the city-state Hamburg (Behörde für Gesundheit
und Verbraucherschutz, Fachbereich Veterinärwessen, from 21.04.2015)
and the animal care committee of the University Medical Center Hamburg-
Eppendorf. The mice used in this study were bred and maintained in the
animal facility of the Center of Molecular Neurobiology of Hamburg
(ZMNH), Hamburg, Germany. Snell’s waltzermice carrying a spontaneously
arisen ∼1.0 kb genomic deletion in Myo6 were obtained from The Jackson
Laboratory (B6×STOCK Tyrc-ch Bmp5se +/+ Myo6sv/J; stock no. 000578)
and were repeatedly backcrossed to C57BL/6J to obtain Myo6sv/+ mice
carrying the Snell’s waltzer allele but lacking the Tyrc-ch and Bmp5se alleles
(Avraham et al., 1995).
Organotypic hippocampal cultures, electroporation and two-
photon microscopy
Hippocampal slice cultures were prepared using female rat pups (Wistar) at
P5–6 as described previously (Gee et al., 2017). No antibiotics were used
during the preparation or in the culture medium. At DIV 7–9, cultures were
transfected with a 1:1.5 mixture of expression vectors encoding tdimer2
(Campbell et al., 2002) and ER–EGFP (Holbro et al., 2009) each driven by
the synapsin-1 promoter, using a Helios gene gun (Bio-Rad). Imaging of
organotypic hippocampal cultures was performed 2–3 weeks after gene
transduction. Z-stacks of apical dendrites from CA1 expressing neurons
were acquired using a custom-built two-photon imaging setup. It was based
on an Olympus BX51WI microscope equipped with a LUMFLN 60×W 1.1
NA objective (Olympus), controlled by the open-source software package
ScanImage (Pologruto et al., 2003) written in Matlab (Mathworks). A
pulsed Ti:Sapphire laser (MaiTai DeepSee, Spectra Physics) controlled by
an electro-optic modulator (350-80, Conoptics) was used to excite tdimer2
and ER–EGFP simultaneously at 980 nm. Emitted photons were collected
through objective and oil-immersion condenser (1.4 NA, Olympus) with
two pairs of photomultiplier tubes (PMTs, H7422P-40, Hamamatsu). 560
DXCR dichroic mirrors and 525/50 and 607/70 emission filters (Chroma
Technology) were used to separate green and red fluorescence. Excitation
light was blocked by short-pass filters (ET700SP-2P, Chroma). Slices were
submerged in artificial cerebrospinal fluid (ACSF) containing (in mM): 127
NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 25 NaHCO3, 1.25 NaH2PO4 and 25 D-
glucose (pH 7.4, ∼308 mOsm, saturated with 95% O2/5% CO2) at room
temperature. After two-photon live imaging, slices were fixed overnight at
4°C in a 2% (w/v) PFA/sucrose mixture and used for post hoc staining with
anti-synaptopodin antibody.
Immunohistochemistry and imaging of organotypic slices
For immunostaining, organotypic slices were washed three times in PBS,
followed by overnight permeabilization with 1% Triton X-100 at room
temperature. In between each of the following steps, using PBS-based
solutions, the slices were washed in PBS. For quenching, slices were
submerged in glycine (50 mM) for 1 h. Afterwards, Image-iT Fx enhancer
(Thermo Fisher Scientific) was used to avoid unspecific labelling. Slices
were incubated with rabbit primary antibody against rat synaptopodin
(Sigma-Aldrich #S9442, 1:1000) for 24 h at 4°C. Next, the slices were
incubated with secondary antibody Alexa Fluor 488-conjugated goat-anti-
rabbit-IgG (1:1000) for 12 h at 4°C. Finally, the slices were washed and
mounted using the Prolong Antifade Kit (Thermo Fisher Scientific).
Images were taken using an Olympus FV300 confocal microscope
equipped with an UPLSAPO 60×1.35 NA objective (Schindelin et al.,
2012).
Subcellular fractionation and synaptosome enrichment
The whole brain of an adult, female rat was homogenized in cold
homogenization buffer (0.32 M sucrose, 5 mM HEPES, pH 7.4) in a ratio
1 g of tissue to 15 ml of buffer, using a Dounce homogenizer at 900 rpm. All
steps were performed on ice or at 4°C. The homogenate was centrifuged for
10 min at 1000 g, the supernatant (S1) was removed and kept on ice. The
pellet was re-suspended in homogenization buffer and homogenized again
in a Dounce homogenizer. After a second centrifugation step for 10 min at
1000 g, the supernatant (S1′) was combined with S1 and centrifuged for
15 min at 12,000 g. The supernatant (S2) was removed, and the pellet was
re-homogenized in homogenization buffer and centrifuged at 12,000 g for
20 min. The resulting pellet (P2′, enriched in synaptosomes and small
vesicular organelles) was resuspended in homogenization buffer. For
immunostaining, the sample was fixed by adding 2.7% Roti-Histofix (Carl
Roth), 2.7% sucrose and incubated for 1 h at room temperature. Glass
coverslips were coated with poly-L-lysine (Sigma-Aldrich) for 4 h at room
temperature and washed five times with milliQ H2O. 10 µl droplets of the
fixed microsome fraction were put on top of a parafilm surface, poly-L-
lysine-coated coverslips were placed on the droplets face-down and
incubated for 25 min at room temperature. Then the coverslips were
flipped and washed three in PBS. Staining with antibodies against
synaptopodin, shank3 and myosin V or VI was performed as described
under in the immunocytochemistry section. The samples were imaged using
a Leica TCS SP5 confocal microscope.
Primary neuronal culture and transfections
Primary hippocampal rat cultures were essentially prepared as described
previously (Kapitein et al., 2010). In brief, hippocampi were dissected from
E18 embryos, treated with trypsin (0.25%, Thermo Fisher Scientific) for
10 min at 37°C, physically dissociated by pipetting through a syringe, and
plated on 18 mm glass coverslips coated with poly-L-lysine (Sigma-
Aldrich) at a density of 40,000–60,000 cells/ml and covered in DMEM
(Gibco) with 10% fetal calf serum (FCS; Gibco) and penicillin/streptomycin
(Thermo Fisher Scientific). After 1 h, the medium was replaced by
BrainPhys neuronal medium supplemented with SM1 (Stem Cell # 5792)
and 0.5 mM glutamine (Thermo Fisher Scientific) without antibiotics. Cells
were then kept in an incubator at 37°C, 5% CO2 and 95% humidity. Primary
hippocampal rat cultures were transfected with Lipofectamine 2000
(Thermo Fisher Scientific) according to the manufacturer’s introductions
and as described previously (Kapitein et al., 2010).
Primary hippocampal mouse cultures from Myo6sv/sv and Myo6+/+ mice
were prepared as described previously (Spilker et al., 2016). Briefly,
hippocampi were dissected frommale and female P0Myo6sv/sv andMyo6+/+
mice and cells were dissociated after 10 min treatment with trypsin at 37°C.
Neurons were plated on glass dishes coated with poly-L-lysine (Sigma-
Aldrich) at a density of 30,000 cells per well in a 12-well plate) in DMEM
(Gibco) supplemented with 8% FCS, 1% penicillin/streptomycin.
Following attachment, mouse cultures were kept in Neurobasal medium
(Gibco) supplemented with 2 mM glutamine, 1% penicillin/streptomycin
and 1× B27 supplement (Gibco), at 37°C, 5% CO2 and 95% humidity.
Dissociated cerebellar cultures containing Purkinje cells were prepared
and transfected as described in detail previously (Wagner et al., 2011b).
Western blot analysis of synaptopodin expression
At DIV5, DIV10, DIV15 and DIV21, cells were harvested by removing the
medium and adding SDS sample buffer [250 mMTris-HCl, pH 6.8, 8% (w/v)
SDS, 40% (v/v) glycerol, 5% (v/v) β-mercaptoethanol and 0.004%
Bromophenol Blue, pH 6.8) directly to the well. In an initial western blot
against β-actin, the intensity of the actin band in each sample was measured
with the gel analyzer/plot lanes function of ImageJ. For the final western blot,
the inputs were normalized to contain the same amount of β-actin, as a loading
control, and synaptopodin levels were detected using a synaptopodin antibody
(Synaptic Systems #163002).
Production of AAVand infection of primary hippocampal neurons
Adeno-associated viruses were produced at the Vector Facility of the
University Medical Center Hamburg-Eppendorf (UKE). pAAV-hSyn1-
mRuby2 (Addgene 99126; deposited by Viviana Gradinaru) and pAAV-
hSyn1-GFP-synaptopodin (this study) were respectively packaged by pE2/
rh10 and p5E/9 (Julie C. Johnston, University of Pennsylvania, USA) and
pHelper (CellBiolabs). For infection with AAV, the viruses were added
directly into the culture medium at final concentrations of between 109 and
1011 vg/ml. pSyn-GFP-Synaptopodin AAV9 was added to the culture at
DIV10, mRuby2 AAVrh10 was added on DIV14, and cells were imaged on
DIV17.
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Immunocytochemistry
Cells were fixed in 4% Roti-Histofix (Carl Roth), 4% sucrose in PBS for
10 min at room temperature and washed three times with PBS, before they
were permeabilized in 0.2% Triton X-100 in PBS for 10 min. After three
washes in PBS, coverslips were incubated in blocking buffer (BB, 10%
horse serum and 0.1% Triton in PBS) for 1 h at room temperature.
Incubation with primary antibodies was performed in BB at 4°C overnight.
After three washes in PBS, cells were incubated with corresponding
secondary antibodies in BB for 1 h at room temperature. If the staining
included phalloidin, an additional step was added where the coverslips were
incubated with phalloidin-647N (1:40) overnight at 4°C. Finally, the
coverslips were washed five times in PBS and mounted in mowiol.
Confocal microscopy – fixed and live cell imaging
Z-stack images of fixed primary hippocampal neurons and fixed
synaptosomal preparations were acquired on Leica TCS SP8 and Leica
TCS SP5 confocal microscopes using a 63.0×1.40 NA oil objective using
488 nm, 568 nm and 633 nm excitation lasers. The pixel size was set to
90 nm and Z-steps varied between 250 and 350 nm. For the shown
representative confocal images, a Gaussian filter (radius 0.5 px) was applied
in ImageJ to reduce the visible background noise. Live Purkinje cells were
imaged at 37°C on a Zeiss LSM 510 confocal microscope equipped with a
100×1.40 NA oil objective exactly as described previously (Wagner et al.,
2011a,b).
Analysis and quantification synaptopodin colocalization with
homer1 or the ER
All of the following quantifications were undertaken from confocal Z-stack
images of fixed and stained neurons. Z-stacks of dendrites were projected
into one plane using the Z projection function of Fiji/ImageJ (Max
Intensity). Per cell, between one and four dendritic segments of ∼40–60 µm
length were selected and used for manual quantification as outlined below.
The detailed information on the number of dendrites and cells is indicated in
the corresponding figure legends.
For initial quantification of density and localization of synaptopodin
puncta during neuronal development (Fig. 2A), untreated hippocampal
neurons were fixed and stained against synaptopodin andMAP2 (a dendritic
marker). The number of synaptopodin puncta that were localized inside the
dendrite (as judged by MAP2 staining) or outside the dendrite (interpreted
as filopodia or spine localization) were counted.
For quantification of synaptopodin localization with respect to
developing synapses, untreated hippocampal neurons were fixed and
stained against synaptopodin, homer1 (synaptic marker) and phalloidin (F-
actin marker). Spines were defined as protrusions from the main dendrite
that were positive for homer1.
To assess the effects of myosin V and myosin VI, DN or control
constructs (mCerulean or YFP) were transfected on DIV16; cells were fixed
on DIV17 and stained against synaptopodin and homer1 (Fig. 4; Fig. S4).
Spines were defined as protrusions from the main dendrite that were positive
for homer1.
Similarly, to quantify spinous localization of synaptopodin and the ER
(Fig. 5), myosin DN or control constructs were co-transfected with an ER–
DsRed marker on DIV16; cells were fixed on DIV17 and stained with anti-
synaptopodin and anti-RFP. Here, spines were defined as spine-shaped
protrusions from the main dendrite as visible in the cell fill.
Fluorescence recovery after photobleaching
Primary hippocampal neurons were co-infected with two AAVs containing
GFP–synaptopodin and mRuby2. mRuby2 was imaged with a 563 nm laser
and the images were used to determine the localization of synaptopodin
puncta. FRAP of GFP–synaptopodin was performed using a Nikon spinning
disc confocal microscope. Time-lapse imaging of GFP–synaptopodin was
performed with a 488 nm laser and bleaching of selected puncta was
achieved with a 405 nm laser. Images were acquired at 0.5 Hz for 300 s,
starting with a five frame baseline before FRAP. FRAP analysis was
undertaken using the plug in Time Series Analyzer V3 of Fiji (NIH,
Bethesda, MD, USA). Regions of interest (ROIs) were selected on the
bleached (‘frapped’) synaptopodin puncta, on a non-bleached stretch of
dendrite to account for bleaching during imaging (bleach control) and on a
non-fluorescent region to account for background fluctuations. The
integrated density values of those ROIs were measured, the background
values were subtracted from the values of GFP–synaptopodin puncta, then
GFP–synaptopodin values were normalized to the bleach control and to the
pre-bleach value (i.e. the pre-beach value was considered as 100%).
STED imaging
Confocal and STED images of phalloidin (Atto647N), MAP2 (Alexa Fluor
488) and synaptopodin (Abberior Star 580) were acquired on a Leica TCS
SP8-3X gated STED microscope equipped with a pulsed 775 nm depletion
laser and a pulsed white light laser (WLL) for excitation. For acquiring
images, the Leica oil objective HC APO CS2 100×1.40 NA was used.
Fluorescence of the respective channel was excited by the WLL at 650 nm
(STED and confocal), 488 nm (confocal mode) and 561 nm (STED and
confocal), respectively. For STED imaging, emission was acquired at 660–
730 nm for Atto-647N and 580–620 nm for Abberior Star 580. The detector
time gates for both STED channels were set from 0.5–1 ns to 6 ns. Both dyes
were depleted with 775 nm. Images were taken as single planes of with
18 nm2 pixel size.
Analysis of STED data
The number, size and integrated fluorescence intensity of synaptopodin
patches, the presence of F-actin and association with homer1 or MAP2 were
analyzed using Fiji. 2D STED images of dendritic stretches were used for
analysis. ROIs around synaptopodin patches were drawn manually in the
synaptopodin channel and, subsequently, integrated intensities within these
ROIs were measured in the F-actin channel. Colocalization of synaptopodin
with homer1 or MAP2 was scored manually by the presence or absence of a
signal in the respective channels inside of the synaptopodin ROI.
Differentiation between spine- and shaft-associated was based on the
proximity to clearly discernable dendritic spines (not further than 0.5 µm
from the spine base).
Wide field and TIRF microscopy: live cell imaging
Live cell wide-field and TIRF imaging for GFP–synaptopodin motility
analysis was performed on a Nikon Eclipse Ti-E controlled by VisiView
software (VisitronSystems). The microscope was equipped with 488 nm,
561 nm and 640 nm excitation laser lines via a multi-mode fiber. Oblique
and TIRF illuminations were achieved with an ILAS2 TIRF system. The
angle of the excitation light was adjusted manually to achieve an optimal
signal-to-noise ratio. Samples were imaged with a 100× TIRF objective
(Nikon, ApoTIRF 100×/1.49 oil). Emission light was captured through a
quad-band filter (Chroma, 405/488/561/640) followed by a filter wheel with
filters for GFP (Chroma, 525/50 m), RFP (Chroma, 595/50 m), and Cy5
(Chroma, 700/75 m). Multi-channel images were acquired sequentially with
an Orca flash 4.0LT CMOS camera (Hamamatsu).
Culturing and transfection of HEK293 cells
HEK293T cells (as described in Mikhaylova et al., 2018) were maintained
in full medium consisting of Dulbecco’s modified Eagle’s medium
(DMEM; GIBCO, Thermo Fisher Scientific) supplemented with 10%
fetal calf serum (FCS), 1×penicillin/streptomycin and 2 mM glutamine at
37°C, 5% CO2 and 95% humidity. For the expression of biotinylated
proteins, HEK293T cells were grown in full medium made with a 50%
DMEM, 50%Ham’s F-10 Nutrient Mix (GIBCO, Thermo Fisher Scientific)
mixture. Transfection was done using MaxPEI 25K (Polysciences) in a 3:1
MaxPEI:DNA ratio.
Pulldown for western blot and mass spectrometry analysis
HEK293T cells were co-transfected with HA–BirA and either
Synaptopodin–pEGFP-bio or pEGFP-bio (control vector) and harvested
after 18 h of expression. The cells were lysed in extraction buffer [20 mM
Tris-HCl pH 8, 150 mM NaCl, 1% Triton X-100, 5 mM MgCl2, complete
protease inhibitor cocktail (Roche)], kept on ice for 30 min and centrifuged
for 15 min at 14,000 g. Magnetic Streptavidin M-280 Dynabeads
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(Invitrogen) were washed three times in washing buffer (20 mM Tris-HCl
pH 8, 150 mM KCl, 0.1% Triton-X 100), blocked in 3% chicken egg
albumin (Sigma-Adlrich) for 40 min at room temperature, and again washed
three times in washing buffer. The cleared cell lysate was added to the
blocked beads and incubated at 4°C on a rotator overnight. After the
incubation period, the beads were washed twice with low-salt washing
buffer (100 mMKCl), twice in high-salt washing buffer (500 mMKCl) and
again twice in low-salt washing buffer. For preparation of whole rat brain
extract, 9 ml lysis buffer [50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1%
SDS, 0.2% NP-40, complete protease inhibitor cocktail (Roche)] were
added per 1 g of tissue weight, and the tissue was lysed using a Dounce
homogenizer. The lysate was cleared first for 15 min at 1000 g, and the
supernatant was again centrifuged for 20 min at 15,000 g to obtain the final
lysate. The washed beads were then combined with 1 ml of the cleared rat
brain lysate and incubated for 1 h at 4°C on a rotator. Finally the beads were
washed five times in washing buffer and resuspended in Bolt LDS sample
buffer (Invitrogen) for subsequent SDS-PAGE. For mass spectrometric
analysis, the samples were separated on a commercial Bolt Bis-Tris Plus Gel
(Invitrogen) and the intact gel was sent to Erasmus MC Proteomics Center,
Rotterdam, for mass spectrometry analysis (see below). For western blot
analysis, the samples were loaded on 4–20% acrylamide gradient gels and
blotted onto PVDF membranes. After blocking in 5% skim milk in Tris-
buffered saline (TBS; 20 mM Tris-HCl pH 7.4, 150 mM NaCl and 0.1%
Tween-20), membranes were incubated with primary antibodies diluted in
TBS-A (TBS pH 7.4, 0.02% sodium azide) overnight at 4°C. Corresponding
HRP-conjugated secondary antibodies and HRP–Strepdavidin were applied
for 1.5 h at room temperature in 5% skimmilk in TBS. The membranes were
imaged on a ChemoCam imager (Intas).
Mass spectrometry analysis
SDS-PAGE gel lanes were cut into 1-mm slices using an automatic gel slicer.
Per sample, eight or nine slices were combined and subjected to in-gel
reduction with dithiothreitol, alkylation with iodoacetamide and digestion
with trypsin (Thermo Fisher Scientific; TPCK treated), essentially as
described by Wilm et al. (1996). Nanoflow LCMS/MS was performed on
an EASY-nLC 1000 Liquid Chromatograph (Thermo Fisher Scientific)
coupled to an Orbitrap Fusion™ Tribrid™ Mass Spectrometer (Thermo
Fisher Scientific) operating in positive mode and equipped with a nanospray
source. Peptide mixtures were trapped on a nanoACQUITY UPLC C18
column (100 Å, 5 µm, 180 µm×20 mm, Waters). Peptide separation was
performed on a ReproSil C18 reversed phase column (Dr Maisch GmbH;
20 cm×100 µm, packed in-house) using a linear gradient from 0 to 80%B [A,
0.1% formic acid; B, 80% (v/v) acetonitrile, 0.1% formic acid] in 60 min and
at a constant flow rate of 500 nl/min. Mass spectra were acquired in
continuum mode; fragmentation of the peptides was performed in data-
dependent mode. Peak lists were automatically created from raw data files
using theMascot Distiller software (version 2.1; MatrixScience). The Mascot
search algorithm (version 2.2, MatrixScience) was used for searching against
a UniProt canonical database (release 2016_07, taxonomies Homo sapiens
and Rattus norvegicus combined). The peptide tolerance was typically set to
10 ppm and the fragment ion tolerance to 0.8 Da. Amaximum number of two
missed cleavages by trypsin were allowed and carbamidomethylated cysteine
and oxidized methionine were set as fixed and variable modifications,
respectively. Quantitative analysis was peformed with MaxQuant software
(version 1.5.4.1) using similar or standard settings and using the UniProt rat
and human isoforms databases (both releases 2016_07).
Network analysis of potential synaptopodin interactors
We selected the 50 proteins that had the highest unique peptide count in the
synaptopodin pulldown (and where unique peptides were at least found at
twice the level as in the negative control) from the mass spectrometry
analysis of synaptopodin interactors (Table S1) for the network analysis
using the ‘Multiple Proteins’ function of the online STRING database
(http://string-db.org; Szklarczyk et al., 2015). The parameters changed from
the default settings were as follows: Network edges: ‘Confidence’ (line
thickness indicates the strength of data support). Active interaction sources:
‘Experiments’ and ‘Databases’. Selected network statistics/Functional
enrichments: Biological Process (GO).
Statistical analysis
Statistical analysis was performed in Statistica 13 (Dell Inc; RM two-way
ANOVA and mixed ANOVA) or in Prism 6.05 (GraphPad; all other tests).
Detailed information about the type of test used, significance levels, n
numbers and biological replicates are provided in the figure legends.
Experimental repeats and n numbers per experiment were chosen according
to experience with effect size. All averaged data are shown as mean±s.e.m.
The data were tested for normality using the D’Agostino-Pearson test
(Prism) and accordingly subjected to a parametric (t-test or ANOVA) or
non-parametric tests (Mann–Whitney test or Kruskal–Wallis test) for
significance. The analysis of the Myo6sv/sv and Myo6+/+ mice data was
performed by researchers who were blind to the genotype of the mice.
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